-
There should be only one priority in clinical research-to put the needs of the consumer first
Simon Denegri
Editorial: Clinical Investigation
-
There should be only one priority in clinical research-to put the needs of the consumer first
Simon Denegri
Editorial: Clinical Investigation
-
There should be only one priority in clinical research-to put the needs of the consumer first
Simon Denegri
Editorial: Clinical Investigation
-
There should be only one priority in clinical research-to put the needs of the consumer first
Simon Denegri
Editorial: Clinical Investigation
-
There should be only one priority in clinical research-to put the needs of the consumer first
Simon Denegri
Editorial: Clinical Investigation
-
There should be only one priority in clinical research-to put the needs of the consumer first
Simon Denegri
Editorial: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Therapeutic targeting of tumor angiogenesis: how far have we come?
Bruce C Baguley & Mark J McKeage
Clinical Trail Outcomes: Clinical Investigation
-
Therapeutic targeting of tumor angiogenesis: how far have we come?
Bruce C Baguley & Mark J McKeage
Clinical Trail Outcomes: Clinical Investigation
-
Therapeutic targeting of tumor angiogenesis: how far have we come?
Bruce C Baguley & Mark J McKeage
Clinical Trail Outcomes: Clinical Investigation
-
Therapeutic targeting of tumor angiogenesis: how far have we come?
Bruce C Baguley & Mark J McKeage
Clinical Trail Outcomes: Clinical Investigation
-
Therapeutic targeting of tumor angiogenesis: how far have we come?
Bruce C Baguley & Mark J McKeage
Clinical Trail Outcomes: Clinical Investigation
-
Therapeutic targeting of tumor angiogenesis: how far have we come?
Bruce C Baguley & Mark J McKeage
Clinical Trail Outcomes: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1
Thomas A Burrow, Gregory A Grabowski
Review Article: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1
Thomas A Burrow, Gregory A Grabowski
Review Article: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1
Thomas A Burrow, Gregory A Grabowski
Review Article: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1
Thomas A Burrow, Gregory A Grabowski
Review Article: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1
Thomas A Burrow, Gregory A Grabowski
Review Article: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1
Thomas A Burrow, Gregory A Grabowski
Review Article: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation